van Schayck CP - Search Results

1

Pharmacogenetics of smoking: how far to the clinic?

Quaak M, van Schooten FJ, van Schayck CP. Quaak M, et al. Among authors: van schayck cp, van schooten fj. Pharmacogenomics. 2014 Apr;15(6):723-6. doi: 10.2217/pgs.14.34. Pharmacogenomics. 2014. PMID: 24897278 No abstract available.

2

Genetic variants in the serotonin transporter influence the efficacy of bupropion and nortriptyline in smoking cessation.

Quaak M, van Schayck CP, Postma DS, Wagena EJ, van Schooten FJ. Quaak M, et al. Among authors: van schayck cp, van schooten fj. Addiction. 2012 Jan;107(1):178-87. doi: 10.1111/j.1360-0443.2011.03534.x. Epub 2011 Sep 21. Addiction. 2012. PMID: 21658141 Clinical Trial.

3

Implications of gene-drug interactions in smoking cessation for improving the prevention of chronic degenerative diseases.

Quaak M, van Schayck CP, Knaapen AM, van Schooten FJ. Quaak M, et al. Among authors: van schayck cp, van schooten fj. Mutat Res. 2009 Jul 10;667(1-2):44-57. doi: 10.1016/j.mrfmmm.2008.10.015. Epub 2008 Nov 5. Mutat Res. 2009. PMID: 19028511 Review.

4

Genetic variation as a predictor of smoking cessation success. A promising preventive and intervention tool for chronic respiratory diseases?

Quaak M, van Schayck CP, Knaapen AM, van Schooten FJ. Quaak M, et al. Among authors: van schayck cp, van schooten fj. Eur Respir J. 2009 Mar;33(3):468-80. doi: 10.1183/09031936.00056908. Eur Respir J. 2009. PMID: 19251795 Free article. Review.

5

[Pharmacogenetics in the treatment of tobacco addiction].

Quaak M, van Schooten FJ, van Schayck CP. Quaak M, et al. Among authors: van schayck cp, van schooten fj. Tijdschr Psychiatr. 2013;55(11):891-8. Tijdschr Psychiatr. 2013. PMID: 24242150 Free article. Review. Dutch.

6

Integrative genomic analysis identifies a role for intercellular adhesion molecule 1 in childhood asthma.

Klaassen EM, van de Kant KD, Jöbsis Q, Penders J, van Schooten FJ, Quaak M, den Hartog GJ, Koppelman GH, van Schayck CP, van Eys G, Dompeling E. Klaassen EM, et al. Among authors: van eys g, van schayck cp, van schooten fj, van de kant kd. Pediatr Allergy Immunol. 2014 Mar;25(2):166-72. doi: 10.1111/pai.12187. Epub 2014 Jan 6. Pediatr Allergy Immunol. 2014. PMID: 24393359

7

Are smokers interested in genetic testing for smoking addiction? A socio-cognitive approach.

Smerecnik C, Quaak M, van Schayck CP, van Schooten FJ, de Vries H. Smerecnik C, et al. Among authors: van schayck cp, van schooten fj. Psychol Health. 2011 Aug;26(8):1099-112. doi: 10.1080/08870446.2010.541909. Epub 2011 Jun 28. Psychol Health. 2011. PMID: 21678175

8

Knowledge, attitudes and preferences regarding genetic testing for smoking cessation. A cross-sectional survey among Dutch smokers.

Quaak M, Smerecnik C, van Schooten FJ, de Vries H, van Schayck CP. Quaak M, et al. Among authors: van schayck cp, van schooten fj. BMJ Open. 2012 Jan 5;2(1):e000321. doi: 10.1136/bmjopen-2011-000321. Print 2012. BMJ Open. 2012. PMID: 22223839 Free PMC article.

9

Addressing passive smoking in children.

Hutchinson SG, Kuijlaars JS, Mesters I, Muris JW, van Schayck CP, Dompeling E, Feron FJ. Hutchinson SG, et al. Among authors: van schayck cp. PLoS One. 2014 May 8;9(5):e93220. doi: 10.1371/journal.pone.0093220. eCollection 2014. PLoS One. 2014. PMID: 24809443 Free PMC article.

10

A randomized controlled trial to assess the effects of reimbursing the costs of smoking cessation therapy on sustained abstinence.

Kaper J, Wagena EJ, Willemsen MC, van Schayck CP. Kaper J, et al. Among authors: van schayck cp. Addiction. 2006 Nov;101(11):1656-61. doi: 10.1111/j.1360-0443.2006.01578.x. Addiction. 2006. PMID: 17034446 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

278 results

Search Page